Biologic Contract Manufacturing WebinarPosted on May 28, 2024 |
![]() |
June 6, 2024, 10:00 a.m. – 12:00 p.m. EST
Michael Hausladen, PhD, General Manager,
LOTTE Biologics
Register in advance for this meeting here.
After registering, you will receive a confirmation email.
Michael Hausladen is the General Manager for LOTTE Biologics USA, LLC, headquartered in Syracuse, NY. LOTTE Biologics is a Contract Development and Manufacturing Organization that is serving the biologic pharmaceutical market. Previous roles at Bristol Myers Squibb (BMS) included starting up the Devens, MA $350M Cell Therapy Facility, managing clinical external biologics manufacturing and various leadership roles including Director of Manufacturing and Director of Manufacturing Technology.
Prior to working in biologics, Michael worked at BMS scaling up and commercialization of enzyme catalyzed and traditional organic synthesis of active pharmaceutical ingredients. Michael has a PhD in chemical engineering from the University at Buffalo.
Other Member News






October 1, 2025Specialists' One-Day Surgery Center Recognized Nationally for Higher Quality and Cost-Effective Spine Surgery and Hip & Knee ReplacementsThis program identifies hospitals and ambulatory care centers (ASCs) that demonstrate expertise in delivering improved patient safety, better health outcomes, and are more cost-effective. |

